Overview
Balance Sheet
Cash Flow
Growth Analysis
2024
2023
2022
2021
2020
Profitability Metrics
Gross Margin
70.59%
Operating Margin
142.61%
Net Margin
75.28%
Efficiency Metrics
Revenue per Expense Ratio
917,174.0
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
142.61%
Income Tax Rate
0.00%
EPS
0.4300000000
Balance Sheet Analysis
Current Ratio
741,995.0
Cash Ratio
792,630.0
Working Capital
$809.57K
Debt to Equity
0.58
Debt to Assets
36.68%
Equity Ratio
62.89%
Cash Flow Analysis
Operating Cash Flow Ratio
303.50%
Free Cash Flow Ratio
303.50%
CapEx to Revenue
0.00%
Dividends Paid
$609.21K
Stock Buybacks
$158.89K
Total Shareholder Returns
$768.09K
Cash Position Change
-99.63%
Key Takeaways (2024 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
1,400.24%
Net Income
185.07%
EPS
184.31%
Operating Income
506.26%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
1.60%
Operating Cash Flow
305.43%
Free Cash Flow
305.43%
Balance Sheet Health
Assets
-9.06%
Debt
-14.73%
Book Value per Share
0.32%
Inventory
0.00%
Shareholder Returns
Dividends per Share
-10.66%
Shares Outstanding
-1.02%
Long Term Trends
3Y Revenue/Share
-35.20%
5Y Revenue/Share
-21.03%
3Y Dividend/Share
-26.81%
5Y Dividend/Share
-27.48%